News tagged with drug prices

Disappointment as breast cancer drug not approved on NHS

The breast cancer drug trastuzumab emtansine (also known as Kadcyla) will not be made routinely available on the NHS following a failure to reach an agreement on price between the National Institute for Health and Care Excellence ...

Aug 11, 2014
popularity0 comments 0

Subscribe to rss feed